Innate Pharma SA (Euronext Paris: FR0010331421 – IPH), the innate immunity company developing first-in-class drugs for cancer and inflammatory diseases, announces its participation in Actionaria, a forum dedicated to meeting with individual investors, on November 18 & 19, in Paris.
- Innate Pharma will present the Company and answer your questions at its stand (A16, level 1).
- Hervé Brailly, Chief Executive Officer, will be at the “Agora of Presidents” on Friday, November 18 at 11:25 am.
| PR in English | 34.32 KB |
| CP en français | 49.59 KB |